Mechanism of Artemisia annua L. in GIOP with kidney-yin deficiency based on network pharmacology
10.12206/j.issn.2097-2024.202204115
- VernacularTitle:基于网络药理学的青蒿治疗肾阴虚型糖皮质激素性骨质疏松机制研究
- Author:
Liyong LAI
1
,
2
;
Tianshuang XIA
2
;
Xiaoqiang YUE
3
;
Hailiang XIN
2
Author Information
1. Department of Pharmacognosy, School of Pharmacy, 1b. School of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China
2. Department of Pharmacognosy, School of Pharmacy, 1b. School of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.
3. Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
- Keywords:
Artemisia annua L.;
kidney-yin deficiency;
glucocorticoid-induced osteoporosis;
dexamethasone;
osteoblast
- From:
Journal of Pharmaceutical Practice
2023;41(11):672-679
- CountryChina
- Language:Chinese
-
Abstract:
Objective To predict and preliminarily verify the potential targets and related signaling pathways of Artemisia annua L. in treating glucocorticoid-induced osteoporosis (GIOP) with kidney-yin deficiency by network pharmacology and in vitro experiments. Methods The pharmacological targets of Artemisia annua L. were obtained from TCMSP database and were converted to gene names through Uniprot database. The target genes of GIOP with kidney-yin deficiency were obtained from GeneCards database, OMIM database and Drugbank database, and the common target genes were obtained by cross analysis with drug target gene. Protein-protein interaction (PPI) network was constructed by String database, and visualization analysis and core targets screening were performed by Cytoscape 3.9.0. All common targets were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis through Metascape database. Finally, the prediction results were verified by in vitro experiments. Results Ninety-eight targets of Artemisia annua L. to GIOP with kidney-yin deficiency were screened, including 17 core genes. The results of GO and KEGG functional enrichment analysis indicated that Artemisia annua L. treating GIOP with kidney-yin deficiency was related to biological processes such as hormonal response, positive regulation of cell death and extracellular stimulation response, et al, as well as signaling pathways such as PI3K/AKT, AGE/RAGE, MAPK and IL-17 et al. The number of genes enriched in PI3K/AKT signaling pathway was the largest. In vitro experiment results showed that Artemisia annua L. promoted the proliferation of osteoblasts damaged by dexamethasone (DEX), increased alkaline phosphatase activity, activated PI3K/AKT pathway, and promoted the phosphorylation of AKT. Conclusion Artemisia annua L. treating GIOP with kidney-yin deficiency has the characteristics of multi-targets and multi-pathway, which could promote the proliferation and differentiation of osteoblasts through multiple pathways. The PI3K/AKT signaling pathway is an important pathway. Artemisia annua L. treating GIOP with kidney-yin deficiency might be related to its ability to promote the PI3K/AKT signaling pathway and promote the phosphorylation of AKT.
